Open AccessFemoston as a hormone replacement therapy for ovarian failure
Author(s) -
М. А. Репина,
Tatyana A. Zinina,
T. M. Korzo
Publication year - 1999
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd88690
Subject(s) - medicine , hemostasis , menstrual cycle , hormone replacement therapy (female to male) , platelet , endocrinology , lipoprotein , coagulation , hormone , broad spectrum , gynecology , pharmacology , cholesterol , chemistry , testosterone (patch) , combinatorial chemistry
The article presents the results of a number of hemostasis parameters (coagulation, vascular and thrombocytic) and lipoprotein spectra, including apo A-1 and apo B100 apoproteins against the background of hormone replacement treatment with Femostone (Solvay, Germany). The results were compared taking into account menstrual cycle phases in perimenopausal patients (with a preserved cycle) and conditional estrogenic, progestagenic phases of Femostone administration. The advantages of the progestagen didrogesterone included in the drug in its effect on the lipid spectrum, apoproteins and some parameters of vascular thrombocyte hemostasis are shown.